Deadline Approaches for APLT Shareholders in Lawsuit
Important Notice for Applied Therapeutics, Inc. Shareholders
The Gross Law Firm is reaching out to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT), emphasizing the critical lead plaintiff deadline. This communication is particularly aimed at those who have acquired shares of APLT during the designated class period.
Registering as a Lead Plaintiff
If you acquired shares of APLT during the class period, you are encouraged to connect with the Gross Law Firm. It’s essential to note that while registering to be a lead plaintiff is not a requirement for claiming any potential recovery, it’s important for those interested in actively participating in this lawsuit.
Class Period Details
The class period for this case spans from January 3, 2024, to December 2, 2024. Anyone who purchased APLT shares during this timeframe should be aware of their rights and the potential for participation in this lawsuit.
The Allegations Against Applied Therapeutics
According to allegations outlined in the complaint, on November 27, 2024, Applied Therapeutics made a significant announcement regarding its lead drug candidate, govorestat. The company disclosed that it received a Complete Response Letter (CRL) regarding its New Drug Application (NDA). This letter indicated that the FDA found deficiencies in the clinical application after conducting a thorough review.
Impact on Stock Prices
Following the disclosure of the CRL, the effect on Applied Therapeutics' stock was immediate and severe. The stock plummeted from a closing price of $10.21 on November 26, 2024, declining to $8.57 the next day. This decline continued, reaching $2.03 on November 29 and dropping further to $1.75 by December 2, indicating a total decrease of over 80% in just a matter of days. The situation worsened after the company revealed it had received a warning letter from the FDA concerning clinical trial issues, leading to additional drops in stock value, which fell to as low as $1.29 by December 5, 2024.
Deadline for Shareholder Registration
The deadline for shareholders to register for this class action lawsuit is February 18, 2025. It’s vital for those affected to take steps promptly to ensure their eligibility. The Gross Law Firm advises that there is no cost associated with registering to participate in this case.
Next Steps for Interested Shareholders
Once you register, your details will be added to a portfolio monitoring system that will provide ongoing updates throughout the legal proceedings. It is a straightforward process designed to keep you informed about the progress of the case.
Why Choose The Gross Law Firm?
The Gross Law Firm is nationally recognized for its adept handling of class action lawsuits. Their mission centers on safeguarding the rights of investors who have suffered losses due to deceptive practices and other illegal business conduct. The firm emphasizes the importance of corporate accountability and strives to protect investors from misleading information that artificially inflates stock prices.
Contact Information
For further inquiries, you can reach out to The Gross Law Firm, located at 15 West 38th Street, 12th floor, New York, NY 10018. You may also contact them via phone at (646) 453-8903 for any additional information regarding this lawsuit.
Frequently Asked Questions
What is the deadline for registering as a lead plaintiff?
The deadline to register as a lead plaintiff in the lawsuit against Applied Therapeutics is February 18, 2025.
Who can register to become a lead plaintiff?
Any shareholder who purchased shares of APLT during the specified class period from January 3, 2024, to December 2, 2024, is eligible to register.
What are the implications of the Complete Response Letter?
The Complete Response Letter from the FDA indicates that the NDA for govorestat could not be approved due to identified deficiencies, impacting stock value significantly.
How can I stay updated on the case?
Once you register, you will be enrolled in a monitoring system that provides regular updates throughout the duration of the case.
Is there any cost to participate in the lawsuit?
No, there is no cost or obligation to participate in the class action lawsuit against Applied Therapeutics.
About The Author
Contact Addison Perry privately here. Or send an email with ATTN: Addison Perry as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
